v3.26.3
SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]    
Total revenue from reportable segments $ 280,007 $ 328,811
Cost of commissions and other services revenue (61,753) (69,101)
Cost of goods sold—pharmacy revenue (155,263) (192,779)
Marketing expense (46,439) (61,947)
Technical development (9,228) (9,911)
Selling, general, and administrative (35,911) (35,819)
All Other Adjusted EBITDA 569 1,888
Corporate (23,799) (25,713)
Share-based compensation expense (2,731) (4,327)
Non-recurring costs (3,851) (185)
Depreciation and amortization (4,460) (4,300)
Loss on disposal of property, equipment, and software, net (74)  
Change in fair value of warrants 12,573 15,036
Interest expense, net (10,966) (11,808)
LOSS BEFORE INCOME TAX BENEFIT (26,517) (37,663)
Unallocated corporate expenses 16,300 17,800
Professional services 3,700 4,100
Facilities 1,100 1,400
Financing transaction costs   100
Severance expenses 3,800 100
Operating Segments    
Segment Reporting [Line Items]    
Total revenue from reportable segments 279,883 326,994
Cost of commissions and other services revenue
Marketing expense
Technical development
Selling, general, and administrative
Adjusted Segment EBITDA 6,222 (8,254)
Operating Segments | Senior    
Segment Reporting [Line Items]    
Total revenue from reportable segments 50,806 58,996
Cost of commissions and other services revenue (36,201) (41,897)
Cost of goods sold—pharmacy revenue 0 0
Marketing expense (26,387) (37,630)
Technical development 0 0
Selling, general, and administrative (521) (505)
Adjusted Segment EBITDA (12,303) (21,036)
Operating Segments | Healthcare Services    
Segment Reporting [Line Items]    
Total revenue from reportable segments 186,278 221,351
Cost of commissions and other services revenue (5,620) (6,301)
Cost of goods sold—pharmacy revenue (153,693) (191,398)
Marketing expense (1,791) (2,389)
Technical development (250) (438)
Selling, general, and administrative (13,693) (13,613)
Adjusted Segment EBITDA 11,231 7,212
Operating Segments | Life    
Segment Reporting [Line Items]    
Total revenue from reportable segments 42,799 46,647
Cost of commissions and other services revenue (15,579) (17,979)
Cost of goods sold—pharmacy revenue 0 0
Marketing expense (19,579) (22,760)
Technical development 0 0
Selling, general, and administrative (347) (338)
Adjusted Segment EBITDA $ 7,294 $ 5,570